Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Weiss

Showing results (281-290 of 296) with videos related to

Pageof 30
Sort By:
Journal of Hepato-Biliary-Pancreatic Sciences|October 6, 2021
Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?Neda Amini, Nikolaos Andreatos, Georgios Antonios Margonis, et al.
Cancer Medicine|June 23, 2017
Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancerBikram Shrestha, Yifei Sun, Farzana Faisal, et al.
The British Journal of Surgery|July 25, 2024
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective studyGeorgios Antonios Margonis, Jaeyun Jane Wang, Thomas Boerner, et al.
Annals of Surgery|December 1, 2022
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical QuestionsGeorgios A Margonis, Thomas Boerner, Jean-Baptiste Bachet, et al.
JAMA Surgery|June 1, 2022
Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver MetastasesDimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2018
Mutations in the pancreatic secretory enzymes <i>CPA1</i> and <i>CPB1</i> are associated with pancreatic cancerKoji Tamura, Jun Yu, Tatsuo Hata, et al.
Cancer Cell|January 26, 2016
Genomic Sequencing Identifies ELF3 as a Driver of Ampullary CarcinomaShinichi Yachida, Laura D Wood, Masami Suzuki, et al.
Journal of the American Medical Informatics Association : JAMIA|June 23, 2016
A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cystsDavid L Masica, Marco Dal Molin, Christopher L Wolfgang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic AdenocarcinomaLei Zheng, Ding Ding, Barish H Edil, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancersJoshua D Cohen, Ammar A Javed, Christopher Thoburn, et al.
Pageof 30

Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Journal of Hepato-Biliary-Pancreatic Sciences|October 6, 2021
Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?Neda Amini, Nikolaos Andreatos, Georgios Antonios Margonis, et al.
Cancer Medicine|June 23, 2017
Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancerBikram Shrestha, Yifei Sun, Farzana Faisal, et al.
The British Journal of Surgery|July 25, 2024
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective studyGeorgios Antonios Margonis, Jaeyun Jane Wang, Thomas Boerner, et al.
Annals of Surgery|December 1, 2022
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical QuestionsGeorgios A Margonis, Thomas Boerner, Jean-Baptiste Bachet, et al.
JAMA Surgery|June 1, 2022
Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver MetastasesDimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2018
Mutations in the pancreatic secretory enzymes <i>CPA1</i> and <i>CPB1</i> are associated with pancreatic cancerKoji Tamura, Jun Yu, Tatsuo Hata, et al.
Cancer Cell|January 26, 2016
Genomic Sequencing Identifies ELF3 as a Driver of Ampullary CarcinomaShinichi Yachida, Laura D Wood, Masami Suzuki, et al.
Journal of the American Medical Informatics Association : JAMIA|June 23, 2016
A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cystsDavid L Masica, Marco Dal Molin, Christopher L Wolfgang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2020
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic AdenocarcinomaLei Zheng, Ding Ding, Barish H Edil, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancersJoshua D Cohen, Ammar A Javed, Christopher Thoburn, et al.
Pageof 30